Designing Peptide Bunches on Nanocage for Bispecific or Superaffinity Targeting

Sooji Kim, Jae Ok Jeon, Eunsung Jun, Jun Goo Jee, Hyun Kyung Jung, Byung Heon Lee, In-San Kim, Soyoun Kim

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Ferritin cage nanoparticles are promising platforms for targeted delivery of imaging and therapeutic agents because their cage structure can accommodate small molecules and their surfaces can be decorated with multiple functionalities. However, selective targeting is still a challenge for translating ferritin-based nanomedicines into the clinic, especially for heterogeneous diseases such as cancer. Targeting peptides can be genetically fused onto the surface of a ferritin cage, forming peptide bunches on nanocages (PBNCs) that offer synergistic increases in binding avidity. Here, we utilized two sites of the ferritin monomer, the N-terminus and the loop between the fourth and fifth helices, which are exposed on the surface of the assembled 24-subunit ferritin cage, to ligate one or two types of peptides to achieve "super affinity"? and bispecificity, respectively. PBNCs formed by ligation of the IL-4 receptor-targeting peptide, AP1, to both sites (48AP1-PBNCs) tethered IL-4R, expressing tumor cells with greater affinity than did PBNCs with AP1 ligated to a single site (24AP1-PBNCs). Moreover, bispecific PBNCs containing 24 RGD peptides and 24 AP1 peptides (24RGD/24AP1-PBNCs) were capable of independently targeting cells expressing the corresponding receptors. Bispecific and superaffinity PBNCs could be useful for efficient targeting of ferritin-based therapeutic/diagnostic agents in a clinical setting.

Original languageEnglish
Pages (from-to)1150-1159
Number of pages10
JournalBiomacromolecules
Volume17
Issue number3
DOIs
Publication statusPublished - 2016 Mar 14

Fingerprint

Peptides
Ferritins
Cells
Interleukin-4 Receptors
Medical nanotechnology
Tumors
Monomers
Nanoparticles
Imaging techniques
Molecules

ASJC Scopus subject areas

  • Bioengineering
  • Biomaterials
  • Polymers and Plastics
  • Materials Chemistry

Cite this

Kim, S., Jeon, J. O., Jun, E., Jee, J. G., Jung, H. K., Lee, B. H., ... Kim, S. (2016). Designing Peptide Bunches on Nanocage for Bispecific or Superaffinity Targeting. Biomacromolecules, 17(3), 1150-1159. https://doi.org/10.1021/acs.biomac.5b01753

Designing Peptide Bunches on Nanocage for Bispecific or Superaffinity Targeting. / Kim, Sooji; Jeon, Jae Ok; Jun, Eunsung; Jee, Jun Goo; Jung, Hyun Kyung; Lee, Byung Heon; Kim, In-San; Kim, Soyoun.

In: Biomacromolecules, Vol. 17, No. 3, 14.03.2016, p. 1150-1159.

Research output: Contribution to journalArticle

Kim, S, Jeon, JO, Jun, E, Jee, JG, Jung, HK, Lee, BH, Kim, I-S & Kim, S 2016, 'Designing Peptide Bunches on Nanocage for Bispecific or Superaffinity Targeting', Biomacromolecules, vol. 17, no. 3, pp. 1150-1159. https://doi.org/10.1021/acs.biomac.5b01753
Kim, Sooji ; Jeon, Jae Ok ; Jun, Eunsung ; Jee, Jun Goo ; Jung, Hyun Kyung ; Lee, Byung Heon ; Kim, In-San ; Kim, Soyoun. / Designing Peptide Bunches on Nanocage for Bispecific or Superaffinity Targeting. In: Biomacromolecules. 2016 ; Vol. 17, No. 3. pp. 1150-1159.
@article{f0c2cd6883f34641b846ef2144dc3ec0,
title = "Designing Peptide Bunches on Nanocage for Bispecific or Superaffinity Targeting",
abstract = "Ferritin cage nanoparticles are promising platforms for targeted delivery of imaging and therapeutic agents because their cage structure can accommodate small molecules and their surfaces can be decorated with multiple functionalities. However, selective targeting is still a challenge for translating ferritin-based nanomedicines into the clinic, especially for heterogeneous diseases such as cancer. Targeting peptides can be genetically fused onto the surface of a ferritin cage, forming peptide bunches on nanocages (PBNCs) that offer synergistic increases in binding avidity. Here, we utilized two sites of the ferritin monomer, the N-terminus and the loop between the fourth and fifth helices, which are exposed on the surface of the assembled 24-subunit ferritin cage, to ligate one or two types of peptides to achieve {"}super affinity{"}? and bispecificity, respectively. PBNCs formed by ligation of the IL-4 receptor-targeting peptide, AP1, to both sites (48AP1-PBNCs) tethered IL-4R, expressing tumor cells with greater affinity than did PBNCs with AP1 ligated to a single site (24AP1-PBNCs). Moreover, bispecific PBNCs containing 24 RGD peptides and 24 AP1 peptides (24RGD/24AP1-PBNCs) were capable of independently targeting cells expressing the corresponding receptors. Bispecific and superaffinity PBNCs could be useful for efficient targeting of ferritin-based therapeutic/diagnostic agents in a clinical setting.",
author = "Sooji Kim and Jeon, {Jae Ok} and Eunsung Jun and Jee, {Jun Goo} and Jung, {Hyun Kyung} and Lee, {Byung Heon} and In-San Kim and Soyoun Kim",
year = "2016",
month = "3",
day = "14",
doi = "10.1021/acs.biomac.5b01753",
language = "English",
volume = "17",
pages = "1150--1159",
journal = "Biomacromolecules",
issn = "1525-7797",
publisher = "American Chemical Society",
number = "3",

}

TY - JOUR

T1 - Designing Peptide Bunches on Nanocage for Bispecific or Superaffinity Targeting

AU - Kim, Sooji

AU - Jeon, Jae Ok

AU - Jun, Eunsung

AU - Jee, Jun Goo

AU - Jung, Hyun Kyung

AU - Lee, Byung Heon

AU - Kim, In-San

AU - Kim, Soyoun

PY - 2016/3/14

Y1 - 2016/3/14

N2 - Ferritin cage nanoparticles are promising platforms for targeted delivery of imaging and therapeutic agents because their cage structure can accommodate small molecules and their surfaces can be decorated with multiple functionalities. However, selective targeting is still a challenge for translating ferritin-based nanomedicines into the clinic, especially for heterogeneous diseases such as cancer. Targeting peptides can be genetically fused onto the surface of a ferritin cage, forming peptide bunches on nanocages (PBNCs) that offer synergistic increases in binding avidity. Here, we utilized two sites of the ferritin monomer, the N-terminus and the loop between the fourth and fifth helices, which are exposed on the surface of the assembled 24-subunit ferritin cage, to ligate one or two types of peptides to achieve "super affinity"? and bispecificity, respectively. PBNCs formed by ligation of the IL-4 receptor-targeting peptide, AP1, to both sites (48AP1-PBNCs) tethered IL-4R, expressing tumor cells with greater affinity than did PBNCs with AP1 ligated to a single site (24AP1-PBNCs). Moreover, bispecific PBNCs containing 24 RGD peptides and 24 AP1 peptides (24RGD/24AP1-PBNCs) were capable of independently targeting cells expressing the corresponding receptors. Bispecific and superaffinity PBNCs could be useful for efficient targeting of ferritin-based therapeutic/diagnostic agents in a clinical setting.

AB - Ferritin cage nanoparticles are promising platforms for targeted delivery of imaging and therapeutic agents because their cage structure can accommodate small molecules and their surfaces can be decorated with multiple functionalities. However, selective targeting is still a challenge for translating ferritin-based nanomedicines into the clinic, especially for heterogeneous diseases such as cancer. Targeting peptides can be genetically fused onto the surface of a ferritin cage, forming peptide bunches on nanocages (PBNCs) that offer synergistic increases in binding avidity. Here, we utilized two sites of the ferritin monomer, the N-terminus and the loop between the fourth and fifth helices, which are exposed on the surface of the assembled 24-subunit ferritin cage, to ligate one or two types of peptides to achieve "super affinity"? and bispecificity, respectively. PBNCs formed by ligation of the IL-4 receptor-targeting peptide, AP1, to both sites (48AP1-PBNCs) tethered IL-4R, expressing tumor cells with greater affinity than did PBNCs with AP1 ligated to a single site (24AP1-PBNCs). Moreover, bispecific PBNCs containing 24 RGD peptides and 24 AP1 peptides (24RGD/24AP1-PBNCs) were capable of independently targeting cells expressing the corresponding receptors. Bispecific and superaffinity PBNCs could be useful for efficient targeting of ferritin-based therapeutic/diagnostic agents in a clinical setting.

UR - http://www.scopus.com/inward/record.url?scp=84960903811&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84960903811&partnerID=8YFLogxK

U2 - 10.1021/acs.biomac.5b01753

DO - 10.1021/acs.biomac.5b01753

M3 - Article

C2 - 26899206

AN - SCOPUS:84960903811

VL - 17

SP - 1150

EP - 1159

JO - Biomacromolecules

JF - Biomacromolecules

SN - 1525-7797

IS - 3

ER -